Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. We are looking to recruit a Development Coordinator to join
-
this important project, the main duty of this post will be to develop, design and validate a Transfusion Platform that will allow for the data linkage between different electronic databases at Barts Health
-
Learning Developer to evolve our digital learning portfolio and enhance online products and services. You will experiment with new content, technologies, and trends to future-proof our portfolio, delivering
-
About the Role This role plays a crucial part in fostering collaborations between the Faculty of Medicine and Dentistry (FMD) at QMUL and industry partners. The Business Development Manager will
-
We are looking for a Principal Educational Developer (New Programmes Project) to join our Education Services. This is an exciting time to join LSHTM as we bring our Vision and Strategy 2022 – 27
-
, Asylum and Nationality Act 2006. Full-Time, Fixed-Term (2 years) Applications are invited for the post of Business and Commercial Development Manager in Royal Holloway Business School (RHBS) Royal
-
-oriented, enthusiastic individual with a bachelor’s degree in life sciences or a related field. Strong ability to manage multiple priorities, meet deadlines, and maintain meticulous attention to detail. Good
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing